Pipeline — registered trials by phase
COVID-19 Active Research Experience (CARE)
— · COVID-19 · Completed · est. 2023-02-23
I-OPERA: A European Study Testing a New Way to Do Health Research.
— · Obesity (Disorder), Overweight , Obesity · Not Yet Recruiting · est. 2027-02
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where IQVIA is lead sponsor; 2 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-23Current report (material event)
- 8-K2026-09-09Current report (material event)
- 10-Q2026-07-28Quarterly report
- 8-K2026-07-28Current report (material event)
- 8-K2026-06-11Current report (material event)
- 8-K2026-06-04Current report (material event)
- 8-K2026-06-03Current report (material event)
- 8-K2026-05-07Current report (material event)
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- S-82026-04-23Employee stock plan
- 8-K2026-04-23Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- ARS2026-02-27Annual report to holders
- DEFA14A2026-02-27DEFA14A
- DEF 14A2026-02-27Proxy statement
- 10-K2026-02-17Annual report
- 8-K2026-02-05Current report (material event)
- 8-K2025-12-09Current report (material event)
- 8-K2025-11-05Current report (material event)
- 10-Q2025-10-28Quarterly report
- 8-K2025-10-28Current report (material event)
- 8-K2025-09-02Current report (material event)
- SCHEDULE 13G/A2025-08-14SCHEDULE 13G/A
- 10-Q2025-07-22Quarterly report
- 8-K2025-07-22Current report (material event)
- 8-K2025-06-04Current report (material event)
- 8-K2025-06-02Current report (material event)
- SCHEDULE 13G/A2025-05-09SCHEDULE 13G/A
- 10-Q2025-05-06Quarterly report
- 8-K2025-05-06Current report (material event)
- 8-K2025-04-24Current report (material event)
- 8-K2025-03-10Current report (material event)
- ARS2025-02-28Annual report to holders
- DEFA14A2025-02-28DEFA14A
- DEF 14A2025-02-28Proxy statement
- PRE 14A2025-02-18PRE 14A
- 10-K2025-02-13Annual report
- 8-K2025-02-06Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.